Voyager Therapeutics Inc’s recently made public that its COO & CBO Swartz Robin unloaded Company’s shares for reported $15713.0 on Jan 14 ’25. In the deal valued at $5.09 per share,3,087 shares were sold. As a result of this transaction, Swartz Robin now holds 109,241 shares worth roughly $0.55 million.
Then, Carter Todd Alfred sold 1,191 shares, generating $6,110 in total proceeds. Upon selling the shares at $5.13, the Chief Scientific Officer now owns 86,436 shares.
Before that, Swartz Robin bought 3,087 shares. Voyager Therapeutics Inc shares valued at $15,721 were divested by the Officer at a price of $5.09 per share.
Cantor Fitzgerald initiated its Voyager Therapeutics Inc [VYGR] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Leerink Partners started covering the stock on October 16, 2024. It rated VYGR as “an Outperform”.
Price Performance Review of VYGR
On Friday, Voyager Therapeutics Inc [NASDAQ:VYGR] saw its stock jump 0.20% to $5.07. Over the last five days, the stock has lost -6.97%. Voyager Therapeutics Inc shares have fallen nearly -10.58% since the year began. Nevertheless, the stocks have fallen -30.55% over the past one year. While a 52-week high of $10.66 was reached on 01/07/25, a 52-week low of $4.99 was recorded on 01/16/25. SMA at 50 days reached $6.02, while 200 days put it at $7.23.
Levels Of Support And Resistance For VYGR Stock
The 24-hour chart illustrates a support level at 5.03, which if violated will result in even more drops to 4.99. On the upside, there is a resistance level at 5.13. A further resistance level may holdings at 5.18. The Relative Strength Index (RSI) on the 14-day chart is 34.22, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.45, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.75%. Stochastics %K at 8.32% indicates the stock is a buying.
How much short interest is there in Voyager Therapeutics Inc?
A steep rise in short interest was recorded in Voyager Therapeutics Inc stocks on 2024-12-31, dropping by 94968.0 shares to a total of 2.46 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 2.56 million shares. There was a decline of -3.86%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 26, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $22 price target.
